Paper408154
Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin.
Bergman Y and 1 other. Eur J Immunol, 1977. Cited by 186 papers, by iCite.
Cite this record
ConductScience Library. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Papers, record 408154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/408154
- Cell line
- 38C132 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Neoplasms, Experimental | Major topic |
| 9,10-Dimethyl-1,2-benzanthracene | |
| Animals | |
| Cell Line | |
| Clone Cells | |
| Electrophoresis, Polyacrylamide Gel | |
| Fluorescent Antibody Technique | |
| Immunoglobulin Fc Fragments | |
| Immunoglobulins | |
| Isoelectric Focusing | |
| Mice | |
| Mice, Inbred C3H | |
| Receptors, Antigen, B-Cell |
Source PubMed
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 186 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23719241 | Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas. | J Immunother | 2013 | https://conductscience.org/library/papers/23719241 | PubMed |
| 23121670 | Enhanced therapeutic effect of B cell-depleting anti-CD20 antibodies upon combination with in-situ dendritic cell vaccination in advanced lymphoma. | Clin Exp Immunol | 2012 | https://conductscience.org/library/papers/23121670 | PubMed |
| 22400032 | Murine models of B-cell lymphomas: promising tools for designing cancer therapies. | Adv Hematol | 2012 | https://conductscience.org/library/papers/22400032 | PubMed |
| 20053640 | ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies). | Protein Eng Des Sel | 2010 | https://conductscience.org/library/papers/20053640 | PubMed |
| 19894105 | Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model. | Pharm Res | 2010 | https://conductscience.org/library/papers/19894105 | PubMed |
| 19690034 | Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas. | J Nucl Med | 2009 | https://conductscience.org/library/papers/19690034 | PubMed |
| 19018479 | Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors. | Immunol Res | 2008 | https://conductscience.org/library/papers/19018479 | PubMed |
| 17993615 | Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo. | Blood | 2008 | https://conductscience.org/library/papers/17993615 | PubMed |
| 17876582 | Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma. | Cancer Immunol Immunother | 2008 | https://conductscience.org/library/papers/17876582 | PubMed |
| 17351111 | A novel proteoliposomal vaccine elicits potent antitumor immunity in mice. | Blood | 2007 | https://conductscience.org/library/papers/17351111 | PubMed |
| 17164345 | Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines. | Blood | 2007 | https://conductscience.org/library/papers/17164345 | PubMed |
| 16034559 | Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia? | Cancer Immunol Immunother | 2006 | https://conductscience.org/library/papers/16034559 | PubMed |
| 12857988 | Rational approaches to immune regulation. | Immunol Res | 2003 | https://conductscience.org/library/papers/12857988 | PubMed |
| 10505101 | Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype. | Gene Ther | 1999 | https://conductscience.org/library/papers/10505101 | PubMed |
| 10404515 | An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. | Mol Med | 1999 | https://conductscience.org/library/papers/10404515 | PubMed |
| 10096292 | Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. | Nat Biotechnol | 1999 | https://conductscience.org/library/papers/10096292 | PubMed |
| 9892697 | Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/9892697 | PubMed |
| 9380720 | Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9380720 | PubMed |
| 8855293 | Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8855293 | PubMed |
| 8469286 | Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. | Nature | 1993 | https://conductscience.org/library/papers/8469286 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/408154
GET https://conductscience.org/api/papers/v1/408154/cited_by?page=2